查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198542

外科牵开器市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Surgical Retractor Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，手术牵开器市场预计将以 7.1% 的复合年增长率增长。

COVID-19 大流行导致许多手术被取消，暂时影响了市场。 手术延期，手术次数减少。 JAMA Network Open 在 2021 年 12 月发表的一项研究发现，在美国，在择期手术最初暂停期间，整体手术率与 2019 年同期相比下降了 48.0%，这就是我的意思。 外科手术的减少导致对外科牵开器的需求减少。 在大流行期间选择急诊手术患者至关重要，以确保术后储备以应对感染 COVID-19 的可能性。 因此，在 COVID-19 大流行期间手术数量减少，影响了市场的增长。 然而，世界各地已恢復推迟的手术，这正在推动大流行后的市场增长。

需要手术的慢性疾病手术数量正在增加，例如外伤、髋/膝关节置换术和心血管疾病。 这是手术牵开器市场的主要增长因素。 例如，2021 年 6 月发表在《胸心血管外科杂誌》上的一项调查研究发现，共有 92,809 例手术被归类为经典意义上的心臟手术，其中 29,444 例为单冠状动脉旁路移植术，35,469 例为单心臟瓣膜手术2020 年手术和单心移植手术增加了 2%，达到 340 例。 因此，预计在预测期内，心臟手术和外科手术的高发率将推动手术牵开器市场的增长。

老年人口的持续增长可能会促进市场的增长。 根据世界卫生组织 2022 年 10 月的更新，到 2030 年，地球上每 6 个人中就有 1 人将超过 60 岁。 预计 60 岁及以上的人口将从 2020 年的 10 亿增长到 2050 年的 14 亿。 到 2050 年，世界 60 岁以上的人口预计将翻一番，达到 21 亿。 2020 年至 2050 年间，80 岁及以上的人口数量预计将增加两倍，达到 4.26 亿。 预计全球老年人口的增加将推动市场增长，因为这个年龄段的人容易患慢性病和手术。 器官移植的增加也有望推动市场增长。 根据HSRA 2022年3月公布的数据，2021年美国进行了约4万例器官移植。 2021 年，美国进行了 26,670 例肾臟移植和 9,236 例活体供体移植。

市场参与者采取的各种举措，例如产品发布、併购和合作伙伴关係，预计将在预测期内推动市场增长。 2021 年 4 月，美敦力 PLC 建立了合作伙伴关係，将 Surgical Theater 的 SyncAR 增强现实（ AR ）技术与美敦力的 StealthStation S8 手术导航系统连接起来。 该合作伙伴关係将使神经外科医生能够实时使用 AR 技术来增强复杂颅骨手术过程中的可视化效果，在某些情况下，还可以增强手术过程中牵开器和其他手术器械的放置。

上述因素预计将推动全球市场增长。 然而，缺乏足够的医疗报酬和对微创手术的偏好增加预计将阻碍预测期内手术牵开器市场的增长。

手术牵开器市场趋势

骨科牵开器领域有望占据主要份额

根据应用，由于骨科手术的增加，骨科牵开器部分预计将保持较高的复合年增长率。 老年人口的增加、导致骨科疾病的事故数量增加以及全球髋关节和膝关节置换手术等因素正在推动这一领域的增长。

根据美国公路交通安全管理局 2022 年 5 月发布的数据，2021 年的交通死亡人数比 2020 年上升了 10.5%。 城市道路死亡人数从 2020 年 3 月的 57.0% 上升到 2021 年 3 月的 62.0%，增幅为 5.0%。 根据世界卫生组织2022年6月发布的数据，道路交通伤害是年轻人（5-29岁）和儿童死亡的主要原因之一。 世界上约 93.0% 的死亡主要发生在低收入和中等收入国家。 由于事故案例的增加，全世界截肢的人数都在增加。 例如，国家医学图书馆 2022 年 1 月发表的一篇论文发现，2005 年截肢患病率为 160 万，预计到 2050 年将翻一番。 上肢截肢的主要原因之一是外伤，占后天截肢的近80.0%。 外科牵开器常用于上肢截肢手术。 预计此类实例将在预测期内推动该细分市场的增长。

上述因素预计将推动骨科手术牵开器的需求，推动预测期内该细分市场的增长。

北美将占据很大的市场份额，预计在预测期内也会如此

北美预计将在预测期内主导市场。 在北美，由于老年人口不断增长、患者人数众多以及外科手术数量不断增加，美国占据了很大份额。 预计在预测期内，妇科手术、腹部手术、心胸外科和骨科手术等手术数量的增加将增加对手术牵开器的需求。

根据阿拉巴马大学伯明翰分校 2021 年 4 月的数据，美国每年进行 350,000 例 CABG 手术。 心血管疾病患病率上升和肥胖率上升是推动该地区市场增长的因素。 例如，根据 CDC 的 2022 年更新，有 1820 万成年人患有冠状动脉疾病，其中约 70% 的患者接受了手术。 美国每年记录的住院人数约为 3500 万。 因此，预计此类医院入院和手术的增加将推动市场增长。 美国不断上升的交通伤害导致外科手术的增加，这反过来又增加了手术牵开器的使用。 根据 ASIRT 于 2022 年 3 月发布的数据，每年有 440 万美国人遭受需要就医的重伤。

根据 Surgical Endoscopy 于 2021 年 11 月发表的一项研究，腹腔镜胆囊切除术是美国最常见的腹部外科手术，每年进行的手术超过 750,000 例。仅此而已。 手术牵开器用于这些手术，预计将促进该国的市场增长。

因此，上述因素预计将在预测期内推动北美市场的增长。

手术牵开器市场竞争者分析

手术牵开器市场高度分散且竞争激烈。 市场参与者正专注于新产品发布、创新和地域扩张，以巩固市场份额。 主要市场参与者包括 Johnson & Johnson (Ethicon)、Becton Dickinson & Company、B. Braun Melsungen AG、Medtronic Plc、Cook Group Inc。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 全球外科手术数量增加
    • 老年人口和生活方式相关疾病的增加
  • 市场製约因素
    • 缺乏足够的医疗报酬
    • 越来越喜欢微创手术
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按类型
    • 手持设备
    • 自我保留
  • 通过申请
    • 骨科牵开器
    • 腹部固定装置
    • 心臟/胸腔牵开器
    • 妇产科牵开器
    • 其他用途
  • 最终用户
    • 医院
    • 门诊手术中心
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Johnson and Johnson（Ethicon）
    • Becton, Dickinson and Company
    • B. Braun Melsungen AG
    • Medtronic PLC
    • Cook Group Incorporated
    • Safe Orthopaedics
    • OBP Medical Corporation
    • Teleflex Incorporated
    • Medline Industries
    • BR Surgical

第7章 市场机会与今后动向

简介目录
Product Code: 68498

The surgical retractors market is expected to register a CAGR of 7.1% over the forecast period.

The COVID-19 pandemic resulted in the cancellation of many surgeries, which had a temporary impact on the market. Surgical procedures were delayed, and the number of surgical procedures decreased. According to a study published in December 2021 by JAMA Network Open, the overall rate of surgical procedures decreased by 48.0% during the initial shutdown of elective procedures compared to the same period in 2019 in the United States. This decline in surgical procedures led to decreased demand for surgical retractors. The selection of patients for urgent surgery during the pandemic was vital to ensure that patients had post-operative reserves to combat any possibility of being infected with COVID-19. Thus, the reduction in the number of surgical procedures during the COVID-19 pandemic affected the market's growth. However, the postponed surgeries resumed worldwide, which has been driving the market's growth during the post-pandemic period.

The number of surgical procedures due to trauma, hip and knee replacements, and chronic diseases such as cardiovascular diseases where surgery is mandatory is growing. This is the primary growth factor for the surgical retractor market. For instance, as per the research study published in June 2021 by the Journal of Thoracic and Cardiovascular Surgery, a total of 92,809 operations were classified as heart surgery procedures in the classical sense, of which 29,444 were isolated coronary artery bypass grafting procedures, 35,469 were isolated heart valve procedures, and the number of isolated heart transplantations increased by 2% to 340 in 2020. Hence, the high number of heart procedures and operations being performed is expected to boost the growth of the surgical retractors market during the forecast period.

The consistent rise in the geriatric population may boost the market's growth. According to the WHO updates from October 2022, one out of every six people on the planet will be 60 years of age or older by 2030. The number of people aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of people aged 60 and above will have doubled to reach 2.1 billion. During 2020-2050, the number of people aged 80 and above is expected to triple, reaching 426 million. Since this age group is more vulnerable to chronic disorders and surgeries, the growing geriatric populace across the world is expected to boost the market's growth. An increase in organ transplants may support the market's growth. According to the data published by the HSRA in March 2022, about 40,000 organ transplants were performed in the United States in 2021. In addition, 26,670 kidney transplants and 9,236 live transplants were performed in the United States in 2021.

Various initiatives taken by the key market players, such as product launches, mergers, acquisitions, and partnerships, are expected to boost the market's growth during the forecast period. In April 2021, Medtronic PLC formed a partnership to interface Surgical Theater's SyncAR augmented reality (AR) technology with Medtronic's StealthStation S8 surgical navigation system. This collaboration will enable neurosurgeons to use AR technology in real-time to enhance visualization during complex cranial procedures and possibly the placement of retractors and other surgical instruments during surgeries.

The above-mentioned factors are expected to drive the market's growth across the world. However, the lack of sufficient reimbursement and the increasing preference for minimally invasive surgery are expected to hamper the growth of the surgical retractor market during the forecast period.

Surgical Retractors Market Trends

Orthopedic Retractors Segment is Expected to Hold a Major Share

By application, the orthopedic retractors segment is anticipated to register a significant CAGR due to the growing number of orthopedic procedures. Factors such as the growing geriatric population, the rising number of accidents leading to permanent orthopedic ailments, and hip and knee replacement procedures around the world are driving the segment's growth.

According to the data published by the National Highway Traffic Safety Administration in May 2022, traffic fatalities increased by 10.5% in 2021 from 2020. Fatalities on urban roads increased from 57.0% in March 2020 to 62.0% in March 2021, registering a growth of 5.0%. According to the data published by the WHO in June 2022, road traffic injuries are one of the leading causes of death among young adults (aged 5 to 29 years) and children. Around 93.0% of the world's fatalities mostly occur in middle- and low-income countries. The increase in accident cases has increased the number of amputations across the world. For instance, according to the article published by the National Library of Medicine in January 2022, the prevalence of amputations was 1.6 million in 2005, which is expected to double by 2050. One of the major causes of upper limb amputations is trauma, which accounts for almost 80.0% of acquired amputations. Surgical retractors are commonly used for amputation surgery. Such instances are anticipated to drive the segment's growth over the forecast period.

The above-mentioned factors are anticipated to propel the demand for orthopedic surgical retractors, driving the segment's growth during the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the market over the forecast period. In North America, the United States held a significant share of the market due to the increasing geriatric population, a large patient population, and a growing number of various surgical procedures. Growth in the number of surgeries, such as gynecological, abdominal, cardiothoracic, and orthopedic surgeries, is expected to boost the demand for surgical retractors during the forecast period.

According to the April 2021 data of the University of Alabama at Birmingham, every year, 350,000 CABG surgeries are performed in the United States. The rising prevalence of cardiovascular disorders and obesity rates is attributed to the market's growth in this region. For instance, according to the CDC's 2022 update, 18.2 million adults had coronary artery disease, and approximately 70% of these patients underwent surgery. The United States records nearly 35 million hospital stays each year. Hence, this rise in hospital stays and surgeries is expected to drive the market's growth. The increasing number of injuries due to road accidents in the United States resulted in increased surgical procedures, thereby increasing the usage of surgical retractors. According to the data published in March 2022 by ASIRT, annually, 4.4 million Americans are injured seriously enough to require medical attention in the United States.

According to a study published in November 2021 by Surgical Endoscopy, laparoscopic cholecystectomy is the most common abdominal surgical treatment in the United States, with over 750,000 procedures performed annually. These procedures use surgical retractors, which is expected to boost the market's growth in the country.

Thus, the aforementioned factors are expected to boost the market's growth in North America over the forecast period.

Surgical Retractors Market Competitor Analysis

The surgical retractors market is highly fragmented and competitive. Market players focus on new product launches, innovations, and geographical expansion to strengthen their market share. The key market players include Johnson & Johnson (Ethicon), Becton, Dickinson and Company, B. Braun Melsungen AG, Medtronic Plc, and Cook Group Incorporated, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Number of Surgical Procedures Worldwide
    • 4.2.2 Increasing Geriatric Population and Lifestyle Related Diseases
  • 4.3 Market Restraints
    • 4.3.1 Lack of Sufficient Reimbursement
    • 4.3.2 Increasing Preference Towards Minimally Invasive Surgery
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Hand Held
    • 5.1.2 Self Retaining
  • 5.2 By Application
    • 5.2.1 Orthopedic Retractors
    • 5.2.2 Abdominal Retractors
    • 5.2.3 Cardiothoracic Retractors
    • 5.2.4 Obstetric or Gynaecological Retractors
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Johnson and Johnson (Ethicon)
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 B. Braun Melsungen AG
    • 6.1.4 Medtronic PLC
    • 6.1.5 Cook Group Incorporated
    • 6.1.6 Safe Orthopaedics
    • 6.1.7 OBP Medical Corporation
    • 6.1.8 Teleflex Incorporated
    • 6.1.9 Medline Industries
    • 6.1.10 BR Surgical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS